This Non-invasive Prenatal Testing Market report provides key statistics on the market status of Global and Regional manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. The report reveals the nature of demand for the firm’s product to know if the demand for the product is constant or seasonal. With this report not only an unskilful individual but also a professional can easily extrapolate the entire market within a few seconds. TOC, graphs and tables included in the report helps understand the market size, share, trends, growth drivers and market opportunities and challenges.
 
Data Bridge Market Research analyses that the non-invasive prenatal testing market which was USD 3.22 billion in 2021, would rocket up to USD 9.06 billion by 2029, and is expected to undergo a CAGR of 13.80% during the forecast period 2022 to 2029.
 
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-invasive-prenatal-testing-market
 
Market Overview:
 
Non-invasive prenatal testing is a DNA-based blood test that is used to assess the risk of genetic disorders in the developing foetus. This is done to see if you have Down syndrome, Patau syndrome, or Edwards syndrome, among other things.
 
After introducing next-generation sequencing technology, it is now possible to sequence foetal DNA fragments that can be built into a whole genetic map, allowing the foetal genome to be inspected prenatally and non-invasively. Novel screening approaches for foetal chromosomal aneuploidies have been developed as a result of advances in molecular technologies and the identification of cell-free foetal DNA in maternal plasma.
 
Some of the major players operating in the non-invasive prenatal testing market are:
 
  • Illumina, Inc. (U.S)
  • Thermo Fisher Scientific Inc. (U.S)
  • General Electric (U.S)
  • BGI Group (China)
  • Agilent Technologies, Inc. (U.S)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • PerkinElmer Inc. (U.S)
  • Laboratory Corporation of America Holdings (U.S)
  • Natera, Inc. (U.S)
  • Yourgene Health (U.S)
  • Eurofins LifeCodexx GmbH (Germany)
  • Quest Diagnostics Incorporated (U.S)
  • Myriad Genetics Inc. (U.S)
  • NIPD Genetics (Cyprus)
  • Next Biosciences (South Africa)
 
Global Non-invasive Prenatal Testing Market Scope:
 
Global non-invasive prenatal testing market is segmented on the basis of product, method, application, test type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
 
Product
  • Products
  • Consumables
  • Assay Kits and Reagents
  • Disposables
  • Instruments
  • NGS Systems
  • PCR Instruments
  • Microarrays
  • Ultrasound Devices
  • Other Instruments
  • Services
 
Method
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests
 
Application
  • Trisomy
  • Microdeletion Syndrome
  • Other Applications
 
Test Type
  • Materni21
  • Harmony
  • Panorama
  • Verify
  • NIFTY
  • Others
 
Technology
  • NGS
  • WGS
  • Others
 
End-User
  • Diagnostic Laboratories
  • Hospitals
 
 
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Non-invasive Prenatal Testing Market Landscape
Part 04: Non-invasive Prenatal Testing Market Sizing
Part 05: Non-invasive Prenatal Testing Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
 
 
Browse Trending Reports:
 
About Data Bridge Market Research:
 
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
 
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
 
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475